TFE, in conjunction with Iron Mountain and WIPP, continue to help Carlsbad lead the way for industrial growth in the region

EDS expands its network of top-rated public safety advocates by adding Frank Rodgers to its advisory board. EDS and The Rodgers Group will work together to increase awareness of the best services available to law enforcement.

Daniel O. Hands of Oakbrook, Illinois, is honored by the International Association of Who's Who as one of Illinois Top Attorneys in Estate Planning Asset Protection for his extensive achievements within the field of Law.

Product photography Los Angeles is oftentimes overlooked by business owners. However, it can serve as one of the most essential marketing tools and LA Photo Team is well aware of this.

Latia Mone will be touring nationwide all fall of 2019 showcasing her talent to colleges and Highschool students. Crank District Entertainment is filled with many great entertainers ready to showcase and perform as well. Most talked about and known.

A national celebration of refugee talents, stories, and accomplishments

BiCupid, a popular bisexual dating site, has been getting a lot of positive reviews of late and it has managed to cross the prestigious 2 million user count.

RHOVIT joins the Algorand community as it announces plans to further democratize cryptocurrency mining with scalable accessibility.

Lectrifi has confirmed that it has officially postponed the launch of its "LectrifiHub" wireless charging hub until 2021.

StoneAge is recognized as a well-rounded company that has mastered a balance of impact, innovation, growth leadership and value.

North America's exclusive dealer of Simpro Bin Dumpers and other materials recovery equipment is back with a whole new look.

Messe Frankfurt Moves Light + Building 2020 Trade Fair from March to September Due to Coronavirus

'Virtual Teams for Dummies' Author Offers Strategies to the New Virtual Workforce

Ms. Marilyn Klinger of Los Angeles, California, is honored by the International Association of Who's Who as one of America's Most Influential Attorneys for her achievements within the field of Law.

Author of 5 bestselling books shares her journey from finding validation from others to receiving validation from God and herself. A Struggle for the Crown that always belonged to her.

to expand its capacity to deliver robotic and IoT enabled solutions to the industrial cleaning industry.

Cynthia Garnholz, of St. Louis, Missouri, is recognized by the International Association of Who's Who as one of America's Most Influential Attorneys for her extensive achievements within the field of Law.

Online summit for birth healing practitioners to help moms heal more completely after birth

Amid COVID-19 quarantine, creativity reigns supreme

Unlike other solutions, AuthorONE delivers explainable, actionable results.

Check with The Online Publishers "TOP platform" first when you need digital marketing solutions and services because it will help you to save both time and money, while also providing you the best options.

This holiday season, instead of gifting your friends and loved ones another meaningless present, let them discover their own unique power with a copy of "Unlocked: Discover How to Embrace the Unexpected" by bestselling author, Dr. Madelyn Blair.

TOP platform is an international campaigner that invites all freelancers no matter where they might be in the world to sign up and explore the opportunity to make money online by offering services through this digital marketing agency.

To better understand data in our organizations, we need to speak a common business language – author Steve Hoberman wrote The Rosedata Stone to show how to create a Business Terms Model to achieve a common business language

Director of Fiscal Policy at the American Action Forum Gordon Gray joins Yahoo Finance’s Seana Smith to break down the April jobs report and how some workers are making more on unemployment compared to their wages before the coronavirus pandemic.

Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst at BofA Securities said Friday that now is the time to go from defensive to offensive in the sector, as quarantines are winding down in several parts of the globe.The Biopharma Analyst Analyst Geoff Meacham shortlisted Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Bristol-Myers Squibb Co (NYSE: BMY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Amgen, Inc. (NASDAQ: AMGN) as biopharma stocks where he would put his money to work.The analyst has the following ratings and price targets for the shares: * Lilly: Buy/$165 * Vertex: Buy/$300 * Bristol-Myers Squibb: Buy/raised the price target from $75 to $80 * BioMarin: Buy/lifted price target from $110 to $120 * Amgen: Buy/price target increased from $265 to $2755 Reasons For BofA's Bullish Disposition BofA is increasingly bullish on the biopharma group due to the following factors, Meacham said: * Expectations for robust revenue growth of 6% in the second half of 2020 compared to the first-half, which is double that of the S&P 500's revenue growth. * Reasonable price-earnings for the stocks in the sector. * Many value-creating events lined up for the second half. * Lower policy risk stemming from goodwill earned from the COVID-19 pipeline. * A consistently positive FDA backdrop.Q1 Earnings Get 'A' Grade All of the big biotechs and major pharma companies reported both revenue and adjusted EPS beats in the first quarter, with Lilly and Vertex even raising some parts of their 2020 guidance, Meacham said.Citing slower new starts and forex headwinds, Bristol-Myers Squibb and BioMarin lowered their 2020 revenue guidance, but maintained their EPS guidance, the analyst said. Meacham expressed surprise at Merck & Co., Inc. (NYSE: MRK) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) lowering their 2020 revenue and adjusted EPS guidance, given his belief that oncology or orphan diseases wouldn't be as sensitive to COVID-19 disruption.See also: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Lilly One of The Higher Quality Stocks In BofA's Coverage Lilly is a source of differentiated growth given its early product cycle and diversified base business, including diabetes, immunology and immunotoxicology and migraine, and an advancing late-stage pipeline of potentially best-in-class or first-in-class therapies, Meacham said.The analyst said he likes Lily's potential for additional earnings growth in 2020-2021 and views Lilly as one of the higher quality stocks in his coverage despite its higher valuation. The prospects for 2021 look attractive, with selpercatinib potentially launching in non-small cell lung cancer and thyroid cancer by year's end, and tirzepatide approval in 2021 representing a "step change" for the diabetes franchise, he said. Consensus For Vertex To Move Higher? Vertex has a richer -- though well-deserved -- valuation, due to its differentiated growth profile, Meacham said.Given that Vertex's commercial execution is largely unaffected by the COVID-19 pandemic, the analyst said investors will begin to look forward to 2021 sooner than for other companies with more commercial risk.BofA expects consensus estimates to continue to move higher, making Vertex's valuation even more attractive.Bristol-Myers Has Highly Differentiated Growth With an estimated 8% revenue growth and 19% EPS growth in 2021 compared to 5-6% and 12%, respectively, for peers, and with six new launches expected this year, 2020 is shaping up to be a very robust period for Bristol-Myers despite the ongoing COVID-19 headwinds, Meacham said. The analyst said the company's growth looks highly differentiated.An increasingly diversified product mix and beatable launch expectations position the company for meaningful upside to consolidated P&L, with improving synergies, he said. BioMarin's 'Game-Changing' Late-Stage Pipeline BioMarin's late-stage pipeline in valrox and vosoritide have improved its growth outlook, Meacham said.The analyst termed the company's late-stage pipeline as "game-changing." The second-half launch of Roctavian is the most important catalyst for the company this year, with the product likely to accelerate the company's already above-average growth profile, he said. "We see BioMarin as one of the higher quality names in our coverage universe given its clean growth story and it remains our SMid cap top pick." Amgen Looks To New Product Growth To Compensate For Legacy Product Erosion The long-term outlook for Amgen's Otezla is improving given the recently announced Phase 3 data for mild-to-moderate psoriasis, Meacham said.The company rapidly refocused its story from legacy product erosion to new product growth with the acquisition of Otezla from the Bristol/Celgene deal, the analyst said. "Since then Amgen's growth profile has only improved, led by an expanded addressable market for Otezla, outperforming Amgen Biosimilars and Evenity franchises, aggressive formulary negotiation for Aimovig, and an exciting pipeline in AMG 510 and tezepelumab looking to contribute as soon as 2021." The Price Action The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) was last seen trading up 1.25% to 128.76, adding to its 5.6% year-to-date gain. Related Link: The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace See more from Benzinga * The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda * The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500 * The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Moody’s Analytics analyzed U.S. metro areas capabilities for a strong recovery post-coronavirus using two primary factors: population density and educational attainment.

What happened to my stimulus money? Many who receive government benefits and others continue to wonder in early May.

Samsung this week released its May 2020 set of security updates for Android smartphones, which includes a patch for a critical vulnerability impacting all of its devices since 2014. 

read more

RideClean is an all-in-one premium ultra polisher & sealer and it's made in the USA.

One-stop destination for selling cars now also offers deals on pre-owned vehicles

Wow beautiful projects there Nima. Peacock is one of my fav subjects to stitch too.

The following is a guest post with simple closet organizing hacks from regular contributor, Morgan from Morganize with Me. Well, with a little more time on my hands, or should I say a lot more time on my hands, I decided to tackle my son’s closet. This was a bit of a spring cleaning/reorganizing project […]

If you're seeing Simple Closet Organizing Hacks to Get the Job Done anywhere other than on I'm an Organizing Junkie (or via my email list or a feed reader) it is being used by someone else without my permission. Please let me know, thank you!

As rumors suggest that Xbox Scarlett is now one console instead of two, we discuss what that means for Xbox heading into the next generation. Plus: Alan Wake 2 is a lot more possible now than it was last week, EA executives forego their bonuses, the co-creator of Dead Space is making a narrative-driven game for PUBG Corp, and more!

#ad #TacoBellPartner First we show off Taco Bell's new Eclipse Xbox One X giveaway bundle (with the new Xbox Elite Series 2 Controller!), and then we discuss Obsidian's new RPG The Outer Worlds with reviewer Dan Stapleton. Plus: Star Wars Jedi: Fallen Order impressions & more!

Call of Duty: Modern Warfare Chad Michael Collins joins us in the second half of the show this week for an interview about acting in one of the biggest games of the year. That interview starts at 42:04 if you'd like to skip straight to it. In the first half of the show, we give our Modern Warfare campaign and multiplayer impressions, detail a fantastic new program from Microsoft that might help ease the sting out of Scarlett's next-gen launch price tag, discuss Fallout 76's new $100 per year service option, and more!

On this week's Xbox podcast, the next Grand Theft Auto is in development, and we discuss the report that it may be a more "moderately sized" offering that's updated continuously. Plus: Microsoft may have an opportunity to gain some market share at the start of the generation after a Bloomberg report reveals Sony's scaled-back PS5 production plans, Crysis is the latest member of the remaster club, and more!

With time-series decomposition, we were able to infer that the consumers were waiting for the highest sale of the year rather than buying up-front.

FREETOWN (Reuters) - Sierra Leone's president Julius Maada Bio has accused the main opposition party of orchestrating a spate of violent incidents, deepening a political standoff that risks undermining the country's efforts to contain a coronavirus outbreak. At least 18 people have died in three riots in separate parts of the country in recent weeks, including a disturbance at Freetown's central prison on April 29 which started after an inmate tested positive for the virus. In a televised address, Bio claimed members of the All People's Congress (APC) party were behind the violence.

The post Sierra Leone’s president accuses main opposition party of inciting violence appeared first on Firstpost.

Patrick Lencioni, author of "Silos, Politics and Turf Wars." Also: HBR articles "Preparing for a Pandemic" and "Inside the Mind of the Chinese Consumer."

Joseph Pine, cofounder of Strategic Horizons LLP and coauthor of "Authenticity: What Consumers Really Want."

Christina Bielaszka-DuVernay, editor of Harvard Management Update.

William Eggers, global research director at Deloitte and coauthor of "If We Can Put a Man on the Moon."

Steve New, head of degree programs at Oxford University's Said Business School and author of the HBR article "The Transparent Supply Chain."

Sherry Turkle, MIT professor and author of "Alone Together: Why We Expect More from Technology and Less from Each Other."

Rob Goffee and Gareth Jones, authors of the HBR article "Creating the Best Workplace on Earth."

The tech luminaries on bundling and unbundling in the digital age.

Steve J. Martin, coauthor of "The Small Big: Small Changes That Spark Big Influence," on the little things that persuade.

Clayton Christensen, professor at Harvard Business School, builds upon the theory of disruptive innovation for which he is well-known. He speaks about his new book examining how successful companies know how to grow.

Andy Molinsky, professor of organizational behavior at Brandeis International Business School, discusses practical techniques for getting outside of your comfort zone, and how that can develop new capabilities and experiences that can help your career. His new book is “Reach: A New Strategy to Help You Step Outside your Comfort Zone, Rise to the Challenge and Build Confidence.”